Redefining neuroprotective gene therapeutic strategies: Lessons learned from caloric restriction and NAD + metabolism

Abstract

Herein a case is made for the development of novel cytoprotective approaches based upon molecular mechanisms thought to underlie the caloric restriction phenomenon. This analysis leads to the prediction that molecular genetic perturbations affecting the metabolism of nuclear NAD⁺ and metabolites will be neuroprotective.